Evidence map›Paper›PMID 32016473›Full record

ArticleMolecular medicine reports2020

Hyperbaric oxygenation improves redox control and reduces mortality in the acute phase of myocardial infarction in a rat model.

Mario S Oliveira, Leonardo Y Tanaka, Ednei L Antonio, Laura I Brandizzi, Andrey J Serra, Leonardo Dos Santos, José E Krieger, Francisco R M Laurindo, Paulo J F Tucci

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Hyperbaric Oxygen Therapy in Experimental Autoimmune Myocarditis: Insights from Preclinical Models to Translational Perspectives.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Survey of Molecular Mechanisms of Hyperbaric Oxygen in Tissue Repair.International journal of molecular sciences · 2021
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mario S OliveiraDivision of Cardiology, Federal University of São Paulo (UNIFESP), São Paulo 04039‑032, Brazil.
Leonardo Y TanakaVascular Biology Laboratory, Heart Institute, University of São Paulo (USP), São Paulo 05403‑900, Brazil.
Ednei L AntonioDivision of Cardiology, Federal University of São Paulo (UNIFESP), São Paulo 04039‑032, Brazil.
Laura I BrandizziVascular Biology Laboratory, Heart Institute, University of São Paulo (USP), São Paulo 05403‑900, Brazil.
Andrey J SerraDivision of Cardiology, Federal University of São Paulo (UNIFESP), São Paulo 04039‑032, Brazil.
Leonardo Dos SantosDepartment of Physiological Sciences, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo 29043‑215, Brazil.
José E KriegerLaboratory of Genetics and Molecular Cardiology, Heart Institute, University of São Paulo (USP), São Paulo 05403‑900, Brazil.
Francisco R M LaurindoVascular Biology Laboratory, Heart Institute, University of São Paulo (USP), São Paulo 05403‑900, Brazil.
Paulo J F TucciDivision of Cardiology, Federal University of São Paulo (UNIFESP), São Paulo 04039‑032, Brazil.
Universidade Federal de São Paulo · BRUniversidade Federal do Espírito Santo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among the mechanisms of action of hyperbaric oxygenation (HBO), the chance of reducing injury by interfering with the mechanisms of redox homeostasis in the heart leads to the possibility of extending the period of viability of the myocardium at risk. This would benefit late interventions for reperfusion to the ischemic area. The objective of the present study was to investigate the changes in the redox system associated with HBO therapy maintained during the first hour after coronary occlusion in an acute myocardial infarction (MI) rat model. Surviving male rats (n=105) were randomly assigned to one of three groups: Sham (SH=26), myocardial infarction (MI=45) and infarction+hyperbaric therapy (HBO=34, 1 h at 2.5 atm). After 90 min of coronary occlusion, a sample of the heart was collected for western blot analysis of total protein levels of superoxide dismutase, catalase, peroxiredoxin and 3‑nitrotyrosine. Glutathione was measured by enzyme‑linked immunosorbent assay (ELISA). The detection of the superoxide radical anion was carried out by oxidation of dihydroethidium analyzed with confocal microscopy. The mortality rate of the MI group was significantly higher than that of the HBO group. No difference was noted in the myocardial infarction size. The oxidized/reduced glutathione ratio and peroxiredoxin were significantly higher in the SH and MI when compared to the HBO group. Superoxide dismutase enzymes and catalase were significantly higher in the HBO group compared to the MI and SH groups. 3‑Nitrotyrosine and the superoxide radical were significantly lower in the HBO group compared to these in the MI and SH groups. These data demonstrated that hyperbaric oxygenation therapy decreased mortality by improving redox control in the hearts of rats in the acute phase of myocardial infarction.

Indexed as

Hyperbaric OxygenationAnimalsCatalaseCoronary OcclusionDisease Models, AnimalGlutathioneMaleMyocardial InfarctionMyocardiumOxidation-ReductionRandom AllocationRatsRats, WistarSuperoxide DismutaseCatalaseGlutathioneSuperoxide Dismutaseantioxidant enzymeshyperbaric oxygenationmortalitymyocardial infarctionnitrationoxidative stressreactive oxygen speciesredox control

Identifiers

PMID32016473
PMCPMC7003025
OpenAlexW3003720721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.